Clinical and electrocardiographic characteristics of immune checkpoint inhibitor-related myocarditis

Author:

Song Wenhua,Chen Ziliang,Zheng Yi,Xu Yu,Sun Yihong,Zhao Zhiqiang,Xie Bingxin,Zhang Nan,Geng Xuhong,Wang Yueying,Zhao Jun,Zhang Xiaowei,Xu Yanmin,Tse Gary,Li Guangping,Hong Lili,Liu Tong

Funder

Project for Key Medicine Discipline Construction of Guangzhou Municipality

National Aerospace Science Foundation of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference32 articles.

1. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors;Hargadon;Int Immunopharmacol,2018

2. Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study;Chan;Cancer Med,2023

3. Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis;Zhou;Cardiooncology,2022

4. Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: A propensity score matched study with competing risk analyses;Zhou;Clin Oncol (R Coll Radiol),2022

5. Case report: cardiac toxicity associated with immune checkpoint inhibitors;Chen;Front Cardiovasc Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3